Singular Genomics Systems Inc (OMIC)
22.75
+0.22
(+0.98%)
USD |
NASDAQ |
Nov 14, 16:00
22.77
+0.02
(+0.09%)
Pre-Market: 08:09
Singular Genomics Systems Cash from Investing (Quarterly): 23.96M for June 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 23.96M |
| March 31, 2024 | 31.58M |
| December 31, 2023 | 0.651M |
| September 30, 2023 | -24.70M |
| June 30, 2023 | -35.09M |
| March 31, 2023 | 72.94M |
| December 31, 2022 | 0.171M |
| September 30, 2022 | -38.12M |
| June 30, 2022 | -10.01M |
| Date | Value |
|---|---|
| March 31, 2022 | 8.386M |
| December 31, 2021 | -23.32M |
| September 30, 2021 | -5.709M |
| June 30, 2021 | -11.37M |
| March 31, 2021 | -90.46M |
| December 31, 2020 | 7.655M |
| September 30, 2020 | 6.547M |
| June 30, 2020 | 7.407M |
| March 31, 2020 | 2.396M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-90.46M
Minimum
Mar 2021
72.94M
Maximum
Mar 2023
-4.282M
Average
0.411M
Median
Cash from Investing (Quarterly) Benchmarks
| Bruker Corp | -67.60M |
| Azenta Inc | 201.62M |
| Harvard Bioscience Inc | -1.111M |
| Bionano Genomics Inc | 28.63M |
| Akoya Biosciences Inc | 9.054M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -18.04M |
| Cash from Financing (Quarterly) | 0.08M |
| Free Cash Flow | -77.98M |
| Free Cash Flow Per Share (Quarterly) | -7.272 |
| Free Cash Flow to Equity (Quarterly) | -16.77M |
| Free Cash Flow Yield | -139.4% |